PLEASANT PRAIRIE — Nexus Pharmaceuticals will build a new three-story manufacturing facility in Pleasant Prairie, investing $250 million over the next 10 years.

A privately-held company that is headquartered in Lincolnshire, Ill., Nexus will build a multi-phase, sterile injectable manufacturing facility in the village’s Prairie Highlands Corporate Park.

Gov. Tony Evers headlined a press conference Wednesday afternoon announcing Nexus’ plans in Pleasant Prairie.

“This is one of the most significant pharmaceutical investments in Wisconsin in years,” Gov. Evers said. “Southeast Wisconsin is increasingly becoming a destination of choice for high-value manufacturing jobs that require a skilled, educated workforce.”

The Pleasant Prairie manufacturing facility will be for production and supply of drugs in an array of therapeutic areas, including anesthesia, oncology, cardiovascular and neurology. Nexus’ proprietary products are currently contract-manufactured by third-party providers located primarily in Europe and the U.S.

“We are proud to call Wisconsin the new home for our company’s first manufacturing facility,” said Nexus CEO Mariam Darsot. “This investment is needed to drive the continued growth of the U.S. pharmaceutical manufacturing industry. There is increasing patient demand for high quality and accessible generic injections. The addition of our Wisconsin facility will enable Nexus to produce a more stable and reliable supply of sterile injectables, a category that is particularly susceptible to drug shortages.”

“It’s a milestone for us,” she said.

Nexus plans to invest $250 million over the the next 10 years and to create 77 new local jobs by 2022.

Initial plans call for a $85 million, three-story facility with cutting edge technology including an advanced isolator system for maximum product protection and sterility to reduce risks of contamination.

The first phase of the project will feature the 100,000-square-foot manufacturing building. Construction is to start later this year with competition in 2021. Commercial production at the plant is slated to begin in 2022.

Joining the governor and company officials were Pleasant Prairie Village Board President John Stinebrink; Kenosha County Executive Jim Kreuser; Todd Battle, the president of the Kenosha Area Business Alliance; and Jeff Ticknor of Milwaukee 7.

“Great things happen every year in Kenosha County,” said Kreuser. “The best thing today is Nexus.”

Battle said Nexus is the kind of company that the community want to have build here.

“Our new facility will employ individuals who demonstrate integrity in their actions and who will work to deliver high quality medications that physicians, pharmacists and nurses rely on every day in the U.S. to treat and save patients’ lives,” said Nexus Vice President John Cook.

Darsot said company management chose Wisconsin and Pleasant Prairie because they provided space to expand the company and the efforts of a “Dream Team” of economic development and government officials.

Nexus Pharmaceuticals, a woman-owned company, is to receive Wisconsin Economic Development Corp. tax incentives of $1.5 million for each of the next four years.

Nexus is the most recent in a long line of companies that have made significant investments in Kenosha County. The company will also receive financial support through the county’s High Impact Fund.

“Kenosha County is pleased to be the selected site for this impactful development,” said Kreuser. “The county worked with the Kenosha Area Business Alliance to establish the High Impact Fund precisely to secure high-quality economic development projects like this one. Nexus Pharmaceuticals is an ideal fit for this program and our community.”

The Milwaukee 7 economic development organization also worked to attract Nexus to the region.

“We’re delighted that Nexus has chosen southeastern Wisconsin for this significant investment,” said Gale Klappa, co-chair of Milwaukee 7 and executive chairman of WEC Energy Group. “Nexus brings the high-value job opportunities that our region seeks and can capably support. The company’s decision to invest here highlights – once again – our success in attracting companies that require skilled knowledge workers.”

The Pleasant Prairie Village Board will consider formal approval of the land purchase and sale agreement for $3.2 million Monday. The agreement is for 16 acres of property located in the northwest quadrant of County Highway Q and 128th Ave. in the corporate park that is just west of Interstate 94.

Nexus will join German candy producer HARIBO and healthcare provider Advocate Aurora as the initial occupants of the park, which is being developed on land the Village purchased from Abbott Laboratories in 2017.